EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 320 filers reported holding EDITAS MEDICINE INC in Q3 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,272,768 | -8.7% | 1,702,030 | -3.7% | 0.00% | -20.0% |
| Q2 2023 | $14,544,015 | +24.5% | 1,767,229 | +9.6% | 0.01% | +25.0% |
| Q1 2023 | $11,684,443 | +79739.0% | 1,611,753 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $14,635 | -99.8% | 1,650,010 | +151.3% | 0.00% | +33.3% |
| Q3 2022 | $8,035,000 | -2.3% | 656,502 | -5.5% | 0.00% | 0.0% |
| Q2 2022 | $8,222,000 | -50.1% | 695,058 | -19.8% | 0.00% | -40.0% |
| Q1 2022 | $16,490,000 | -30.1% | 866,915 | -2.4% | 0.01% | -28.6% |
| Q4 2021 | $23,589,000 | -19.1% | 888,374 | +25.2% | 0.01% | -22.2% |
| Q3 2021 | $29,160,000 | -18.1% | 709,766 | +12.8% | 0.01% | -18.2% |
| Q2 2021 | $35,605,000 | +215.1% | 629,031 | +133.8% | 0.01% | +175.0% |
| Q1 2021 | $11,298,000 | +45.8% | 269,028 | +143.4% | 0.00% | +33.3% |
| Q4 2020 | $7,748,000 | +1398.6% | 110,518 | +500.3% | 0.00% | – |
| Q3 2020 | $517,000 | – | 18,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |